Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients

Completed

• Conditions: Endocarditis, Bacterial

• Registration Number: NCT03306225
• Lead Sponsor: Fondation Hôpital Saint-Joseph

Brief Summary

The infectious endocarditis is a grave infection the incidence of which is at present esteemed at 30-100 episodes by million inhabitants a year.

This infection is marked with a heavy morbi-mortality.Preliminary studies seem to show an abnormally high death rate at the patients presenting an infectious endocarditis to streptococci with an inhibitive minimal concentration raised to the amoxicilline. The aim of the study is to describe the epidemiology and the clinical presentations of the patients presenting an endocarditis to streptococci

Detailed Description

Not available

Study Timeline

• Study Start: 2016-07-08
• Study First Submitted: 2017-10-05
• Study First Submitted QC: 2017-10-09
• Study First Posted: 2017-10-10
• Primary Completion: 2018-12-31
• Study Completion: 2019-12-31
• Status Verified: 2020-01
• Last Update Submitted: 2020-02-03
• Last Update Posted: 2020-02-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 414

Inclusion Criteria

• age > 18 years
• endocartitis with steptococci with Duke's criteria

Exclusion Criteria

• age < 18 years
• suspiscious endocarditis without Duke's criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of factors associated to the mortality in the patients presenting an endocarditis to streptococci.	an average of one year

Trial Locations

Locations (1)

Groupe Hospitalier Paris Saint Joseph; 🇫🇷 Paris, Ile-de-France, France